Details
Stereochemistry | ABSOLUTE |
Molecular Formula | C9H17NO5 |
Molecular Weight | 219.235 |
Optical Activity | UNSPECIFIED |
Defined Stereocenters | 1 / 1 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
CC(C)(CO)[C@@H](O)C(=O)NCCC(O)=O
InChI
InChIKey=GHOKWGTUZJEAQD-ZETCQYMHSA-N
InChI=1S/C9H17NO5/c1-9(2,5-11)7(14)8(15)10-4-3-6(12)13/h7,11,14H,3-5H2,1-2H3,(H,10,15)(H,12,13)/t7-/m0/s1
Molecular Formula | C9H17NO5 |
Molecular Weight | 219.235 |
Charge | 0 |
Count |
|
Stereochemistry | ABSOLUTE |
Additional Stereochemistry | No |
Defined Stereocenters | 1 / 1 |
E/Z Centers | 0 |
Optical Activity | UNSPECIFIED |
Pantothenic acid (known as Vitamin B5) is a water-soluble member of the B-vitamin family that is converted into 4’-phosphopantetheine, which is then converted to co-enzyme A (CoA) via adenosine triphosphate. Pantothenic acid regulates epidermal barrier function and keratinocytes differentiation via CoA metabolism. Pantothenic acid is incorporated into co-enzyme A and protects cells against peroxidative damage by increasing the level of glutathione. A recent feasibility study has also shown that daily oral supplementation of a nutritional agent containing pantothenic acid for 8 weeks was feasible and safe. It was discovered the different pharmacological implementation of pantothenic acid, such as treatment of acne, obesity. Existed some reports, mentioned efficacy using pantothenic acid in systemic lupus erythematosus. Significant reduction in morning stiffness, degree of disability, and severity of pain was reported for persons taking pantothenic acid in case of osteoarthritis and rheumatoid arthritis. Vitamin B5 may increase the effects of a group of drugs called cholinesterase inhibitors, which are used to treat Alzheimer's disease. That might lead to severe side effects.
CNS Activity
Sources: https://www.ncbi.nlm.nih.gov/pubmed/3734807
Curator's Comment: Known to be CNS penetrant in rat. Human data not available
Approval Year
Targets
Primary Target | Pharmacology | Condition | Potency |
---|---|---|---|
Target ID: Q9BZ23|||Q8TCR5 Gene ID: 80025.0 Gene Symbol: PANK2 Target Organism: Homo sapiens (Human) Sources: https://www.ncbi.nlm.nih.gov/pubmed/26549575 |
|||
Target ID: Q8TE04 Gene ID: 53354.0 Gene Symbol: PANK1 Target Organism: Homo sapiens (Human) Sources: https://www.ncbi.nlm.nih.gov/pubmed/26549575 |
Conditions
Condition | Modality | Targets | Highest Phase | Product |
---|---|---|---|---|
Primary | VITAPED Approved UseFor treatment of pernicious anemia (due to lack of or inhibition of intrinsic factor) and for prevention and treatment of vitamin B 12 deficiency. Launch Date1993 |
|||
Sources: https://www.ncbi.nlm.nih.gov/pubmed/24831048 |
Palliative | Unknown Approved UseUnknown |
||
Palliative | Unknown Approved UseUnknown |
|||
Palliative | Unknown Approved UseUnknown |
|||
Palliative | Unknown Approved UseUnknown |
PubMed
Title | Date | PubMed |
---|---|---|
[Evaluation of vitamin B6 and calcium pantothenate effectiveness on hair growth from clinical and trichographic aspects for treatment of diffuse alopecia in women]. | 2001 |
|
Life-threatening eosinophilic pleuropericardial effusion related to vitamins B5 and H. | 2001 Apr |
|
Phosphopantothenoylcysteine synthetase from Escherichia coli. Identification and characterization of the last unidentified coenzyme A biosynthetic enzyme in bacteria. | 2001 Apr 27 |
|
Proliferation of peripheral blood mononuclear cells causes increased expression of the sodium-dependent multivitamin transporter gene and increased uptake of pantothenic acidopen star. | 2001 Aug |
|
CJ-15,801, a novel antibiotic from a fungus, Seimatosporium sp. | 2001 Dec |
|
Significance of pantothenate for glucose fermentation by Oenococcus oeni and for suppression of the erythritol and acetate production. | 2001 Jan |
|
Effect of urea and pantothenol on the permeation of progesterone through excised rat skin from polymer matrix systems. | 2001 Jan |
|
Vitamin requirements of the cultured flesh fly cells, Sarcophaga peregrina (Diptera, Sarcophagidae). | 2001 Jan-Feb |
|
Mechanistic studies on phosphopantothenoylcysteine decarboxylase. | 2001 Jul 4 |
|
Pantothenic acid protects jurkat cells against ultraviolet light-induced apoptosis. | 2001 Jun 1 |
|
Arabidopsis thaliana flavoprotein AtHAL3a catalyzes the decarboxylation of 4'-Phosphopantothenoylcysteine to 4'-phosphopantetheine, a key step in coenzyme A biosynthesis. | 2001 Jun 1 |
|
[Other drugs administered with TPN solution]. | 2001 May |
|
[Micronutrient (vitamins and minerals) supplementation for the elderly, suggested by a special committee nominated by Ministry of Health]. | 2001 Nov |
|
Hypolipidemic effect of pantothenic acid derivatives in mice with hypothalamic obesity induced by aurothioglucose. | 2001 Oct |
|
In vitro regeneration of Hypericum patulum Thunb.--a medicinal plant. | 2001 Sep |
|
Carbon flux analysis in a pantothenate overproducing Corynebacterium glutamicum strain. | 2002 |
|
Topical use of dexpanthenol in skin disorders. | 2002 |
|
Newly established regulation in Japan: foods with health claims. | 2002 |
|
Preparation of pure and intact Plasmodium falciparum plasma membrane vesicles and partial characterisation of the plasma membrane ATPase. | 2002 Apr 26 |
|
Effect of thiamine hydrochloride, pyridoxine hydrochloride and calcium-d-pantothenate on the patulin content of apple juice concentrate. | 2002 Aug |
|
Colorimetric and fluorimetric methods for determination of panthenol in cosmetic and pharmaceutical formulation. | 2002 Feb 1 |
|
Streptomycin revisited: molecular action in the microbial cell. | 2002 Jan |
|
Collagenase treatment of sore nipples. | 2002 Jan |
|
Topical corticosteroid therapy for acute radiation dermatitis: a prospective, randomized, double-blind study. | 2002 Jun |
|
Enhancement of muscular performance by a coformulation of propionyl-L-carnitine, coenzyme Q10, nicotinamide, riboflavin and pantothenic acid in the rat. | 2002 Jun 1 |
|
Complete reconstitution of the human coenzyme A biosynthetic pathway via comparative genomics. | 2002 Jun 14 |
|
Topical estrogens combined with argon plasma coagulation in the management of epistaxis in hereditary hemorrhagic telangiectasia. | 2002 Mar |
|
Characterization of the 5' regulatory region of the human sodium-dependent multivitamin transporter, hSMVT. | 2002 Mar 19 |
|
[Closure of the wound defect by transferred flap of skin]. | 2002 Nov-Dec |
|
Intravenous nutrient therapy: the "Myers' cocktail". | 2002 Oct |
|
[Effect of pantogam on visual function and hemodynamic of eyes in patients with primary open-angle glaucoma]. | 2002 Sep-Oct |
|
[Clinical evaluation of provitamin B5 drops and gel for postoperative treatment of corneal and conjuctival injuries]. | 2003 |
|
Fermentative activity and production of volatile compounds by Saccharomyces grown in synthetic grape juice media deficient in assimilable nitrogen and/or pantothenic acid. | 2003 |
|
Determination of water-soluble vitamins in soft drinks and vitamin supplements using capillary electrophoresis. | 2003 Aug |
|
Structure of E. coli ketopantoate hydroxymethyl transferase complexed with ketopantoate and Mg2+, solved by locating 160 selenomethionine sites. | 2003 Aug |
|
The optimization of HPLC-UV conditions for use with FTIR detection in the analysis of B vitamins. | 2003 Feb |
|
[Ogilvie's syndrome: a rare cause of the acute abdomen]. | 2003 Feb |
|
Specialization of function among aldehyde dehydrogenases: the ALD2 and ALD3 genes are required for beta-alanine biosynthesis in Saccharomyces cerevisiae. | 2003 Jan |
|
Malnutrition in institutionalized seniors: the iatrogenic component. | 2003 Jan |
|
Competitive and interactions affecting a fermentative spirochete in anaerobic chemostats. | 2003 Jul |
|
[The protective effect of dexpanthenol in nasal sprays. First results of cytotoxic and ciliary-toxic studies in vitro]. | 2003 Mar |
|
Transport of biotin in human keratinocytes. | 2003 Mar |
|
Pharmacotherapy for dyslipidaemia--current therapies and future agents. | 2003 Nov |
|
Metabolic network analysis during fed-batch cultivation of Corynebacterium glutamicum for pantothenic acid production: first quantitative data and analysis of by-product formation. | 2003 Sep 4 |
|
Determination of vitamin B5 in a range of fortified food products by reversed-phase liquid chromatography-mass spectrometry with electrospray ionisation. | 2004 Apr 2 |
|
Fluorimetric determination of pantothenic acid in foods by liquid chromatography with post-column derivatization. | 2004 Apr 30 |
|
Clear hydro-gel, compared to ointment, provides improved eye comfort after brief surgery. | 2004 Feb |
|
Prevention of tungiasis using a biological repellent: a small case series. | 2004 Jan |
|
Organisation of the pantothenate (vitamin B5) biosynthesis pathway in higher plants. | 2004 Jan |
|
Coenzyme A biosynthesis: reconstruction of the pathway in archaea and an evolutionary scenario based on comparative genomics. | 2004 Jul |
Patents
Sample Use Guides
In Vivo Use Guide
Sources: http://www.altmedrev.com/publications/16/3/263.pdf
The Dietary Reference Intake (DRI) established by the Institute of Medicine for pantothenic acid is as follows: 1–3 years old: 2 mg/d; 4–8 years old: 3 mg/d; 9–13 years old: 4 mg/d; 14 years old and over: 5 mg/d; Pregnancy: 6 mg/d; Lactation: 7 mg/d
Route of Administration:
Oral
Substance Class |
Chemical
Created
by
admin
on
Edited
Fri Dec 15 14:59:26 GMT 2023
by
admin
on
Fri Dec 15 14:59:26 GMT 2023
|
Record UNII |
19F5HK2737
|
Record Status |
Validated (UNII)
|
Record Version |
|
-
Download
Name | Type | Language | ||
---|---|---|---|---|
|
Official Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Common Name | English |
Classification Tree | Code System | Code | ||
---|---|---|---|---|
|
LOINC |
27351-6
Created by
admin on Fri Dec 15 14:59:26 GMT 2023 , Edited by admin on Fri Dec 15 14:59:26 GMT 2023
|
||
|
LIVERTOX |
NBK548710
Created by
admin on Fri Dec 15 14:59:26 GMT 2023 , Edited by admin on Fri Dec 15 14:59:26 GMT 2023
|
||
|
LOINC |
75066-1
Created by
admin on Fri Dec 15 14:59:26 GMT 2023 , Edited by admin on Fri Dec 15 14:59:26 GMT 2023
|
||
|
DSLD |
1791 (Number of products:46)
Created by
admin on Fri Dec 15 14:59:26 GMT 2023 , Edited by admin on Fri Dec 15 14:59:26 GMT 2023
|
||
|
NCI_THESAURUS |
C45812
Created by
admin on Fri Dec 15 14:59:26 GMT 2023 , Edited by admin on Fri Dec 15 14:59:26 GMT 2023
|
||
|
LOINC |
2722-7
Created by
admin on Fri Dec 15 14:59:26 GMT 2023 , Edited by admin on Fri Dec 15 14:59:26 GMT 2023
|
||
|
DSLD |
2547 (Number of products:2298)
Created by
admin on Fri Dec 15 14:59:26 GMT 2023 , Edited by admin on Fri Dec 15 14:59:26 GMT 2023
|
||
|
LOINC |
75060-4
Created by
admin on Fri Dec 15 14:59:26 GMT 2023 , Edited by admin on Fri Dec 15 14:59:26 GMT 2023
|
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
16454
Created by
admin on Fri Dec 15 14:59:26 GMT 2023 , Edited by admin on Fri Dec 15 14:59:26 GMT 2023
|
PRIMARY | |||
|
SUB14758MIG
Created by
admin on Fri Dec 15 14:59:26 GMT 2023 , Edited by admin on Fri Dec 15 14:59:26 GMT 2023
|
PRIMARY | |||
|
19F5HK2737
Created by
admin on Fri Dec 15 14:59:26 GMT 2023 , Edited by admin on Fri Dec 15 14:59:26 GMT 2023
|
PRIMARY | |||
|
CHEMBL1594
Created by
admin on Fri Dec 15 14:59:26 GMT 2023 , Edited by admin on Fri Dec 15 14:59:26 GMT 2023
|
PRIMARY | |||
|
m8388
Created by
admin on Fri Dec 15 14:59:26 GMT 2023 , Edited by admin on Fri Dec 15 14:59:26 GMT 2023
|
PRIMARY | Merck Index | ||
|
PANTOTHENIC ACID
Created by
admin on Fri Dec 15 14:59:26 GMT 2023 , Edited by admin on Fri Dec 15 14:59:26 GMT 2023
|
PRIMARY | |||
|
29032
Created by
admin on Fri Dec 15 14:59:26 GMT 2023 , Edited by admin on Fri Dec 15 14:59:26 GMT 2023
|
PRIMARY | |||
|
100000091279
Created by
admin on Fri Dec 15 14:59:26 GMT 2023 , Edited by admin on Fri Dec 15 14:59:26 GMT 2023
|
PRIMARY | |||
|
6613
Created by
admin on Fri Dec 15 14:59:26 GMT 2023 , Edited by admin on Fri Dec 15 14:59:26 GMT 2023
|
PRIMARY | |||
|
201-229-0
Created by
admin on Fri Dec 15 14:59:26 GMT 2023 , Edited by admin on Fri Dec 15 14:59:26 GMT 2023
|
PRIMARY | |||
|
DB01783
Created by
admin on Fri Dec 15 14:59:26 GMT 2023 , Edited by admin on Fri Dec 15 14:59:26 GMT 2023
|
PRIMARY | |||
|
79-83-4
Created by
admin on Fri Dec 15 14:59:26 GMT 2023 , Edited by admin on Fri Dec 15 14:59:26 GMT 2023
|
PRIMARY | |||
|
62400
Created by
admin on Fri Dec 15 14:59:26 GMT 2023 , Edited by admin on Fri Dec 15 14:59:26 GMT 2023
|
ALTERNATIVE | |||
|
46905
Created by
admin on Fri Dec 15 14:59:26 GMT 2023 , Edited by admin on Fri Dec 15 14:59:26 GMT 2023
|
PRIMARY | |||
|
1020
Created by
admin on Fri Dec 15 14:59:26 GMT 2023 , Edited by admin on Fri Dec 15 14:59:26 GMT 2023
|
PRIMARY | |||
|
7891
Created by
admin on Fri Dec 15 14:59:26 GMT 2023 , Edited by admin on Fri Dec 15 14:59:26 GMT 2023
|
PRIMARY | |||
|
D010205
Created by
admin on Fri Dec 15 14:59:26 GMT 2023 , Edited by admin on Fri Dec 15 14:59:26 GMT 2023
|
PRIMARY | |||
|
C47783
Created by
admin on Fri Dec 15 14:59:26 GMT 2023 , Edited by admin on Fri Dec 15 14:59:26 GMT 2023
|
PRIMARY | |||
|
19F5HK2737
Created by
admin on Fri Dec 15 14:59:26 GMT 2023 , Edited by admin on Fri Dec 15 14:59:26 GMT 2023
|
PRIMARY | |||
|
176840
Created by
admin on Fri Dec 15 14:59:26 GMT 2023 , Edited by admin on Fri Dec 15 14:59:26 GMT 2023
|
PRIMARY | |||
|
DTXSID9023417
Created by
admin on Fri Dec 15 14:59:26 GMT 2023 , Edited by admin on Fri Dec 15 14:59:26 GMT 2023
|
PRIMARY | |||
|
SUB127094
Created by
admin on Fri Dec 15 14:59:26 GMT 2023 , Edited by admin on Fri Dec 15 14:59:26 GMT 2023
|
PRIMARY | |||
|
7916
Created by
admin on Fri Dec 15 14:59:26 GMT 2023 , Edited by admin on Fri Dec 15 14:59:26 GMT 2023
|
PRIMARY |
Related Record | Type | Details | ||
---|---|---|---|---|
|
SALT/SOLVATE -> PARENT |
|
||
|
SALT/SOLVATE -> PARENT |
|
||
|
PARENT -> CONSTITUENT ALWAYS PRESENT |
Nutritional value per 100 g (3.5 oz) - 0.573 mg (11%)
|
||
|
SALT/SOLVATE -> PARENT |
|
||
|
SALT/SOLVATE -> PARENT | |||
|
SALT/SOLVATE -> PARENT | |||
|
SALT/SOLVATE -> PARENT |
|
||
|
ENANTIOMER -> ENANTIOMER |
|
||
|
SALT/SOLVATE -> PARENT |
|
Related Record | Type | Details | ||
---|---|---|---|---|
|
ACTIVE MOIETY |
|